Urinary Tract Infection
📧 Sign up to get email alerts when something new happens for Urinary Tract Infection.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2015-03-16FDA Approved: AUGMENTIN ES-600 — Supplemental Application (USAntibiotics, LLC)
FDA approved a supplemental application for AUGMENTIN ES-600 by USAntibiotics, LLC, updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Family Physicians
Abbott-sponsored clinical trial completed to assess antibiotic susceptibility in urinary tract infection patients seen by family physicians.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Computer-Assisted Treatment of Urinary Tract Infection in Emergency Departments and Community Health Centers [NA]
The clinical trial evaluating computer-assisted treatment of urinary tract infections in emergency departments and community health centers …
-
CLINICAL_TRIALS research · 2015-02-23Clinical Trial Update: Urinary Tract Infections in Older Persons Admitted to a Psychogeriatric Ward [NA]
This is a clinical trial update from KU Leuven about urinary tract infections in older adults admitted to a psychogeriatric ward. The curren…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Open Label Trial of Nissle 1917 [Phase 1]
An open-label Phase 1 trial of Nissle 1917 for urinary tract infections has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-01-15FDA Approved: NITROFURANTOIN (MACROCRYSTALS) — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Nitrofurantoin (Macrocrystals) from Aurobindo Pharma Limited, indicating regulatory approval of …
-
FDA approval · 2015-01-15FDA Approved: NITROFURANTOIN (MACROCRYSTALS) — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Nitrofurantoin (Macrocrystals) from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine Leiomyomata
A completed clinical trial update about evaluating lower urinary tract infection in women with uterine fibroids (leiomyomata).
-
CLINICAL_TRIALS research · 2015-01-06Clinical Trial Update: To Study the Effect of Adjunctive Oral Methylprednisolone Therapy in Pediatric Urinary Tract Infection [Phase 3]
A Phase 3 trial is evaluating adjunctive oral methylprednisolone therapy for pediatric urinary tract infection.
-
FDA approval · 2014-12-21FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for sulfamethoxazole and trimethoprim from Amneal Pharmaceuticals of New York LLC. The approval cove…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections [Phase 4]
A Phase 4 clinical trial completed evaluating the efficacy and safety of Cipro XR (ciprofloxacin extended-release) for treating lower urinar…
-
CLINICAL_TRIALS withdrawal · 2014-12-16Clinical Trial Update: Cranberry on Urinary Tract Infections [Phase 4]
Phase 4 trial evaluating cranberry for urinary tract infections has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products [NA]
A completed ClinicalTrials.gov study evaluated urinary Proanthocyanidin-A2 as a biomarker of adherence to cranberry product intake, with res…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: A Phase IV Study of Cipro XR in Uncomplicated UTI [Phase 4]
A Phase IV study evaluating Cipro XR (ciprofloxacin extended-release) for uncomplicated urinary tract infections has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Colonizing Neurogenic Bladders With Benign Flora [Phase 1]
Phase 1 trial evaluating colonizing neurogenic bladders with benign flora in people with spinal cord injury and urinary tract infection. Res…
-
FDA approval · 2014-11-08FDA Approved: LEVOFLOXACIN — Supplemental Application (Sagent Pharmaceuticals)
The FDA approved a supplemental application for Levofloxacin submitted by Sagent Pharmaceuticals, approving changes to the generic labeling …
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: Treatment's Duration of Acute Uncomplicated Pyelonephritis [Phase 4]
Phase 4 clinical trial update announcing the completion of a study evaluating the optimal duration of treatment for acute uncomplicated pyel…
-
FDA approval · 2014-11-03FDA Approved: NITROFURANTOIN — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for nitrofurantoin submitted by Rising Pharma Holdings, Inc. to modify the labeling and/or indic…
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: Multifaceted Treatment of Catheter-related Urinary Tract Infection [Phase 2]
Phase 2 clinical trial update on multifaceted treatment for catheter-related urinary tract infection in patients with spinal cord injury and…
-
EMA withdrawal · 2014-10-17EMA Withdrawn: Doribax (doripenem) — Janssen-Cilag International NV
Doribax (doripenem) has been withdrawn from the European market by Janssen-Cilag International NV due to regulatory decision.
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI) [Phase 3]
Phase 3 trial update on Canephron N for uncomplicated urinary tract infections reports safety and efficacy results.
-
FDA approval · 2014-09-08FDA Approved: NITROFURANTOIN — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' nitrofurantoin as an Original Application generic product.
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: Immediate vs. Conditional Use of Antibiotics in Uncomplicated Urinary Tract Infection (UTI) - ICUTI [Phase 4]
Phase 4 clinical trial comparing immediate versus conditional use of antibiotics for uncomplicated urinary tract infection has completed. No…
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection [Phase 2]
Phase 2 trial update for intravaginal LACTIN-V aimed at preventing recurrent urinary tract infections has completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI) [Phase 3]
Phase 3 trial assessing safety and efficacy of phenazopyridine hydrochloride 200 mg tablets for short-term relief in women with uncomplicate…